Live feed
·
PRReleasevia Quantisnow
Lantheus Holdings Inc. logo

Lantheus Receives FDA Tentative Approval for Lutetium Lu 177 Dotatate (PNT2003), Radioequivalent to LUTATHERA®

ByQuantisnow·Wall Street's wire, on your screen.
LNTH· Lantheus Holdings Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track LNTH (Lantheus Holdings Inc.) and more on Quantisnow.